Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1971 1
1972 2
1974 2
1975 7
1976 4
1977 9
1978 3
1979 5
1980 4
1981 6
1982 8
1983 16
1984 7
1985 10
1986 12
1987 14
1988 29
1989 16
1990 11
1991 20
1992 24
1993 22
1994 17
1995 16
1996 20
1997 13
1998 16
1999 16
2000 19
2001 18
2002 15
2003 17
2004 21
2005 20
2006 21
2007 24
2008 29
2009 21
2010 18
2011 24
2012 19
2013 38
2014 35
2015 35
2016 37
2017 32
2018 30
2019 25
2020 40
2021 32
2022 29
2023 26
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

888 results

Results by year

Filters applied: . Clear all
Page 1
A Review of Chronic Granulomatous Disease.
Arnold DE, Heimall JR. Arnold DE, et al. Adv Ther. 2017 Dec;34(12):2543-2557. doi: 10.1007/s12325-017-0636-2. Epub 2017 Nov 22. Adv Ther. 2017. PMID: 29168144 Free PMC article. Review.
Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by defects in any of the five subunits of the NADPH oxidase complex responsible for the respiratory burst in phagocytic leukocytes. ...
Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by defects in any of the five subunits of the
Chronic Granulomatous Disease.
Rawat A, Bhattad S, Singh S. Rawat A, et al. Indian J Pediatr. 2016 Apr;83(4):345-53. doi: 10.1007/s12098-016-2040-3. Epub 2016 Feb 11. Indian J Pediatr. 2016. PMID: 26865172 Review.
Chronic granulomatous disease (CGD) is the most common symptomatic phagocytic defect. ...
Chronic granulomatous disease (CGD) is the most common symptomatic phagocytic defect. ...
Pediatric inflammatory adenopathy.
Penn EB Jr, Goudy SL. Penn EB Jr, et al. Otolaryngol Clin North Am. 2015 Feb;48(1):137-51. doi: 10.1016/j.otc.2014.09.010. Otolaryngol Clin North Am. 2015. PMID: 25439552 Review.
Noninfectious Manifestations and Complications of Chronic Granulomatous Disease.
Henrickson SE, Jongco AM, Thomsen KF, Garabedian EK, Thomsen IP. Henrickson SE, et al. J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S18-S24. doi: 10.1093/jpids/piy014. J Pediatric Infect Dis Soc. 2018. PMID: 29746679 Free PMC article. Review.
Chronic granulomatous disease (CGD), a primary immunodeficiency characterized by a deficient neutrophil oxidative burst and the inadequate killing of microbes, is well known to cause a significantly increased risk of invasive infection. ...
Chronic granulomatous disease (CGD), a primary immunodeficiency characterized by a deficient neutrophil oxidative burst
Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.
Chiriaco M, Salfa I, Di Matteo G, Rossi P, Finocchi A. Chiriaco M, et al. Pediatr Allergy Immunol. 2016 May;27(3):242-53. doi: 10.1111/pai.12527. Epub 2016 Jan 21. Pediatr Allergy Immunol. 2016. PMID: 26680691 Review.
Chronic granulomatous disease (CGD) is a rare primary immunodeficiency caused by defects in the genes encoding any of the NADPH oxidase components responsible for the respiratory burst of phagocytic leukocytes. ...
Chronic granulomatous disease (CGD) is a rare primary immunodeficiency caused by defects in the genes encoding any of t
Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease.
Chandrasekaran P, Han Y, Zerbe CS, Heller T, DeRavin SS, Kreuzberg SA, Marciano BE, Siu Y, Jones DR, Abraham RS, Stephens MC, Tsou AM, Snapper S, Conlan S, Subramanian P, Quinones M, Grou C, Calderon V, Deming C, Leiding JW, Arnold DE, Logan BR, Griffith LM, Petrovic A, Mousallem TI, Kapoor N, Heimall JR, Barnum JL, Kapadia M, Wright N, Rayes A, Chandra S, Broglie LA, Chellapandian D, Deal CL, Grunebaum E, Lim SS, Mallhi K, Marsh RA, Murguia-Favela L, Parikh S, Touzot F, Cowan MJ, Dvorak CC, Haddad E, Kohn DB, Notarangelo LD, Pai SY, Puck JM, Pulsipher MA, Torgerson TR, Kang EM, Malech HL, Segre JA, Bryant CE, Holland SM, Falcone EL. Chandrasekaran P, et al. J Allergy Clin Immunol. 2023 Dec;152(6):1619-1633.e11. doi: 10.1016/j.jaci.2023.07.022. Epub 2023 Sep 1. J Allergy Clin Immunol. 2023. PMID: 37659505 Free article.
BACKGROUND: Chronic granulomatous disease (CGD) is caused by defects in any 1 of the 6 subunits forming the nicotinamide adenine dinucleotide phosphate oxidase complex 2 (NOX2), leading to severely reduced or absent phagocyte-derived reactive oxygen species p …
BACKGROUND: Chronic granulomatous disease (CGD) is caused by defects in any 1 of the 6 subunits forming the nicotinamid …
Late diagnosis of chronic granulomatous disease.
Barkai T, Somech R, Broides A, Gavrieli R, Wolach B, Marcus N, Hagin D, Stauber T. Barkai T, et al. Clin Exp Immunol. 2020 Sep;201(3):297-305. doi: 10.1111/cei.13474. Epub 2020 Jul 13. Clin Exp Immunol. 2020. PMID: 32506450 Free PMC article.
In this study we present a retrospective cohort of 16 patients diagnosed with Chronic Granulomatous Disease (CGD) at adulthood. Some of the patients had a milder clinical phenotype, but others had a classic phenotype with severe infectious and inflammatory co …
In this study we present a retrospective cohort of 16 patients diagnosed with Chronic Granulomatous Disease (CGD) at ad …
Recent topics and advanced therapies in chronic granulomatous disease.
Nunoi H, Nakamura H, Nishimura T, Matsukura M. Nunoi H, et al. Hum Cell. 2023 Mar;36(2):515-527. doi: 10.1007/s13577-022-00846-7. Epub 2022 Dec 19. Hum Cell. 2023. PMID: 36534309 Review.
Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by the inability of phagocytes to produce reactive oxygen species (ROS) owing to a defect in any of the five components (CYBB/gp91phox, CYBA/p22phox, NCF1/p47phox, NCF2/p67phox, a
Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by the inability of phagocytes to produ
Gene Therapy Approaches to Immunodeficiency.
Ghosh S, Gaspar HB. Ghosh S, et al. Hematol Oncol Clin North Am. 2017 Oct;31(5):823-834. doi: 10.1016/j.hoc.2017.05.003. Epub 2017 Jun 29. Hematol Oncol Clin North Am. 2017. PMID: 28895850 Free article. Review.
This review reflects the progresses made in specific disorders, including adenosine deaminase deficiency, X-linked severe combined immunodeficiency, chronic granulomatous disease, and Wiskott-Aldrich syndrome....
This review reflects the progresses made in specific disorders, including adenosine deaminase deficiency, X-linked severe combined immunodef …
888 results